映恩生物-B(09606.HK):穩定價格行動及穩定價格期間結束
格隆匯5月12日丨映恩生物-B(09606.HK)發佈公吿,有關全球發售的穩定價格期間於2025年5月10日(星期六)(即遞交香港公開發售申請截止日期後第30日)結束。穩定價格操作人摩根士丹利亞洲有限公司或其聯屬人士或代其行事的任何人士於穩定價格期間進行的穩定價格行動載列如下:
(1)於國際發售超額分配合共259.98萬股股份,佔全球發售項下可供認購發售股份總數的約15%(經計及發售量調整權已獲悉數行使但於行使超額配股權之前);
(2)Morgan Stanley & Co International plc(穩定價格操作人摩根士丹利亞洲有限公司的聯屬人士)根據借股協議自DualityBio Ltd.借入合共259.98萬股股份以補足國際發售項下的超額分配;及
(3)聯席代表(為其本身及代表國際承銷商)於2025年5月6日(星期二)按每股股份94.60港元(即全球發售項下每股股份的發售價,不包括1%經紀佣金、 0.0027%證監會交易徵費、0.00565%聯交所交易費及0.00015%會財局交易徵費)悉數行使超額配股權,涉及合共259.98萬股股份,以促成向DualityBio Ltd.歸還借股協議項下用於補足國際發售項下超額分配的259.98萬股借入股份。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.